External validation of precisebreast, a digital prognostic test for predicting breast cancer recurrence, in an early-stage cohort from the Netherlands.

Breast Cancer Res · 2025 · PMC12369158 · PMID 40836358

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

trending towards significanceno p-value reported

Furthermore, performance of the PDxBR clinical versus PDxBR AI-grade model was not statistically different ( p = 0.076), although trending towards significance.

also in 181 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.